[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.216.242. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Invited Commentary
March 23, 2009

Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults—Invited Commentary

Arch Intern Med. 2009;169(6):578-579. doi:10.1001/archinternmed.2008.594

More than 30 prospective studies involving more than 250 000 people have demonstrated that fasting TG concentrations are associated with an excess risk of coronary disease even after controlling for other risk factors.1 With the exception of patients with familial hypertriglyceridemia, there is little doubt that TG concentration represents an important risk factor. The population-based report by Ford et al is of interest because it demonstrates that this risk factor is found in more than 30% of the population.

First Page Preview View Large
First page PDF preview
First page PDF preview
×